Skip to main content
. 2021 Sep 8;2021:2939162. doi: 10.1155/2021/2939162

Figure 4.

Figure 4

Comparison of progression-free survival of patients with stage IIB cervical cancer between different subgroups of (a) PLR, (b) NLR, (c) MLR, (d) BLR, and (e) SIRI.